Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced in Q4 CY2024, with sales up 4.6% year on year to $460.9 ...
Privia Health Gr (NASDAQ:PRVA) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...
Privia Health Group Inc (NASDAQ:PRVA) exceeded the high end of all guidance metrics for 2024, showcasing strong performance across all markets. Implemented providers increased by 11.2% year over ...
Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q4 CY2024, with sales up 4.6% year on year to $460.9 million. On the other hand, the company’s ...